Riddhi Siddhi Gluco Biols Board Meeting Scheduled for May 19, 2026 to Approve FY26 Financial Results and Dividend

1 min read     Updated on 14 May 2026, 12:15 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Riddhi Siddhi Gluco Biols Limited has scheduled a Board of Directors meeting for May 19, 2026, to approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The Board will also consider recommending a dividend on equity shares for FY26. The Trading Window for designated persons has been closed since April 1, 2026, and will remain shut until 48 hours after the results are declared.

powered bylight_fuzz_icon
40286710

*this image is generated using AI for illustrative purposes only.

Riddhi Siddhi Gluco Biols Limited has notified BSE Limited of an upcoming Board of Directors meeting, scheduled for Tuesday, May 19, 2026. The intimation, dated May 14, 2026, was filed pursuant to Regulation 29 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Agenda Items

The Board meeting has been convened to address the following matters:

Agenda Item: Details
Financial Results: Audited Standalone and Consolidated results for the Quarter and Financial Year ended March 31, 2026
Dividend Consideration: To consider and recommend dividend, if any, on Equity Shares for the Financial Year ended March 31, 2026
Meeting Date: Tuesday, May 19, 2026
Regulatory Reference: Regulation 29 and 33 of SEBI (LODR) Regulations, 2015

Trading Window Closure

In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the Company's Code of Conduct for Prohibition of Insider Trading, the Trading Window for dealing in the securities of the Company has been closed for all Designated Persons and their immediate relatives with effect from April 1, 2026. The Trading Window will remain closed until 48 hours after the declaration of financial results for the quarter and financial year ended March 31, 2026.

The intimation was signed by Sharad Jain, Company Secretary (Membership No. F13058), on behalf of Riddhi Siddhi Gluco Biols Limited.

Historical Stock Returns for Riddhi Siddhi Gluco Biols

1 Day5 Days1 Month6 Months1 Year5 Years
+0.48%-8.14%+21.78%+24.40%+16.39%+135.77%

How have Riddhi Siddhi Gluco Biols' revenue and profit margins trended over the past three financial years, and what growth trajectory might the FY2026 audited results reveal?

Given the current sugar and starch industry dynamics, will the board likely recommend a dividend for FY2026, and how does the company's dividend history compare to sector peers?

How might fluctuations in raw material costs, particularly maize and sugarcane prices, have impacted Riddhi Siddhi Gluco Biols' consolidated financial performance for FY2026?

Riddhi Siddhi Gluco Biols
View Company Insights
View All News
like20
dislike

Riddhi Siddhi Gluco Biols Promoter Proposes OFS of 8.23 Lakh Shares to Achieve MPS Compliance

2 min read     Updated on 09 Apr 2026, 09:16 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Riddhi Siddhi Gluco Biols promoter Mr. Ganpatraj Lalchand Chowdhary has proposed to sell 8,23,422 equity shares (11.55% of total paid-up capital) through OFS mechanism to achieve minimum public shareholding compliance. The proposal follows SAT order dated 9th March, 2026, which modified earlier SEBI directions. Post-OFS, promoter shareholding will be 75% while public shareholding will reach the mandatory 25% threshold. The company will make further disclosures upon receiving final confirmation from the promoter and will take necessary steps for regulatory approvals and intermediary appointments.

powered bylight_fuzz_icon
37251980

*this image is generated using AI for illustrative purposes only.

Riddhi Siddhi Gluco Biols has received a formal proposal from promoter Mr. Ganpatraj Lalchand Chowdhary to sell a significant portion of his shareholding through an Offer for Sale (OFS) mechanism. The proposal, communicated on 8th April, 2026, aims to ensure compliance with minimum public shareholding norms following regulatory directions.

Proposed Share Sale Details

The promoter has expressed intention to divest 8,23,422 equity shares through the OFS mechanism via stock exchange platform. This represents a substantial portion of the company's equity base and demonstrates commitment to regulatory compliance.

Parameter Details
Shares to be Sold 8,23,422 equity shares
Percentage of Total Capital 11.55%
Sale Mechanism Offer for Sale (OFS)
Platform Stock Exchange

Post-OFS Shareholding Structure

Upon completion of the proposed OFS, the company's shareholding pattern will be restructured to meet regulatory requirements. The distribution will achieve the mandatory minimum public shareholding threshold.

Shareholder Category Number of Equity Shares Percentage (%)
Promoters/Promoters Group 53,47,339 75.00
Public 17,82,447 25.00
Total 71,29,786 100.00

Regulatory Background

The OFS proposal stems from compliance requirements following a Securities Appellate Tribunal order dated 9th March, 2026. This order modified earlier SEBI directions regarding minimum public shareholding compliance that were originally issued on 11th August, 2021. The SAT order specifically reduced the restraint period from two years after MPS compliance to six months after such compliance.

The original SEBI order had directed the company to comply with MPS requirements within five months and imposed certain restraints on market access until compliance was achieved. The company had challenged these directions before the Securities Appellate Tribunal through Appeal Nos. 543 and 588 of 2021.

Next Steps and Approvals

The company has indicated it will make further disclosures in accordance with Regulation 30 and applicable SEBI circulars upon receiving final confirmation from the promoter. The proposal requires evaluation of necessary approvals, appointment of required intermediaries under the SEBI OFS framework, and appropriate notifications to stock exchanges as per SEBI (LODR) Regulations, 2015.

The promoter has requested the company to take all necessary steps to facilitate the OFS process, including obtaining requisite approvals and appointing necessary intermediaries as required under regulatory guidelines. This structured approach ensures compliance with all applicable SEBI circulars and guidelines for OFS transactions.

Historical Stock Returns for Riddhi Siddhi Gluco Biols

1 Day5 Days1 Month6 Months1 Year5 Years
+0.48%-8.14%+21.78%+24.40%+16.39%+135.77%

How might the increased public float of 25% impact Riddhi Siddhi Gluco Biols' stock liquidity and institutional investor interest?

What strategic initiatives could the company pursue with the proceeds from this OFS to enhance shareholder value?

Will the promoter's reduced stake from 86.55% to 75% signal a shift toward more professional management or board restructuring?

Riddhi Siddhi Gluco Biols
View Company Insights
View All News
like17
dislike

More News on Riddhi Siddhi Gluco Biols

1 Year Returns:+16.39%